Abzena
Biopharmaceuticals are an increasingly important class of medicines with over 400 products.
Abzena has raised €28M across 1 funding round, most recently a round in Jul 2014. Based in London, UK; founded 2007. Data as of 28 Oct 2026.
Total raised
€28M
€27,800,000
Funding rounds
1
Investors
0
distinct backers
Active since
2014-07
latest 2014-07
Funding by year
EUR raised per yearAbzena — funding by year — interactive chart.
Data table
| Abzena — funding by year | |
|---|---|
| 2014 | €28M |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-07-01 | Other | €28M | — | View deal → |
Similar companies
same sector or countryGlobal coverage: FundingData